https://theprint.in/health/all-about-leqembi-new-alzheimers-drug-thats-likely-to-get-us-approval-and-its-risks/1655322/
0
0
7/5/23 at 11:57am
Organization
ThePrint
Author
Mohana Basu
If it gets FDA's nod this week, it will be the second in a new category of medications to treat mild to moderate cases of the neurodegenerative disease in the US.
Create an account
or login to join the discussion